Latest Us Expansion News

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

AML3D has received a pivotal Letter of Intent from the US Navy, outlining plans for additive manufacturing collaboration and significant demand growth through 2030.

Cobram Estate Olives has reported a record 2025 Australian olive harvest with a 10.2% increase in production and forecasts a strong FY2025 EBITDA of $115 million. The company also announces strategic moves including a CEO relocation to the US and acquisition of farming machinery business Leda Ag.

The Calmer Co. International Limited has reported a striking 86% revenue jump to over AU$8 million in FY25, propelled by diversified sales channels and a strategic US expansion highlighted by new flavoured kava shots launched exclusively on Amazon USA.

Trigg Minerals has raised A$12.5 million from institutional and strategic investors to accelerate development of its Antimony Canyon Project in Utah, positioning itself as a key supplier in the US critical minerals market amid soaring antimony prices.

Silver Mines Limited has completed its acquisition of the Calico North Project and initiated an earn-in agreement for up to 80% of the Kramer Hills Project in California, marking a strategic expansion into a tier-one mining jurisdiction.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

Vitasora Health has expanded its partnership with The Physician Alliance Corporation from a pilot to a multi-year value-based care contract covering up to 15,000 Medicare patients, unlocking significant new revenue streams tied to patient outcomes.

Xero has completed a significant A$1.85 billion institutional placement to fund its acquisition of Melio, aiming to enhance its accounting and payments platform in the US market. A complementary A$200 million Share Purchase Plan will offer retail investors a chance to participate.

Xero Limited has announced a binding agreement to acquire Melio Limited for US$2.5 billion, backed by a fully underwritten A$1.85 billion equity raise. This strategic move aims to accelerate Xero’s US growth and more than double its FY25 revenue by FY28.